Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Neuroscience Letters|August 4, 2010
Chondroitin sulfate demarcates astrocytic territories in the mammalian cerebral cortexNoriko Horii-Hayashi, Kouko Tatsumi, Yumiko Matsusue, et al.
Journal of Neuroscience Research|September 26, 2008
Genetic fate mapping of Olig2 progenitors in the injured adult cerebral cortex reveals preferential differentiation into astrocytesKouko Tatsumi, Hirohide Takebayashi, Takayuki Manabe, et al.
Frontiers in Neuroanatomy|March 3, 2018
Olig2-Lineage Astrocytes: A Distinct Subtype of Astrocytes That Differs from GFAP AstrocytesKouko Tatsumi, Ayami Isonishi, Miwako Yamasaki, et al.
Plos One|June 14, 2013
Oligodendrocyte plasticity with an intact cell body in vitroManabu Makinodan, Aya Okuda-Yamamoto, Daisuke Ikawa, et al.
Nature Immunology|January 26, 2023
Dermal macrophages set pain sensitivity by modulating the amount of tissue NGF through an SNX25-Nrf2 pathwayTatsuhide Tanaka, Hiroaki Okuda, Ayami Isonishi, et al.
Plos One|April 25, 2018
Propofol induces nuclear localization of Nrf2 under conditions of oxidative stress in cardiac H9c2 cellsTakeaki Shinjo, Tatsuhide Tanaka, Hiroaki Okuda, et al.
Plos One|January 26, 2010
Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brainHiroaki Okuda, Ryusuke Kuwahara, Shinsuke Matsuzaki, et al.
Journal of Gastroenterology and Hepatology|February 22, 2023
Pretreatment serum monocyte chemoattractant protein-1 as a predictor of long-term outcome by ustekinumab in patients with Crohn's diseaseHiroaki Okuda, Shuhei Hosomi, Shigehiro Itani, et al.
Scientific Reports|March 19, 2020
Slco2a1 deficiency exacerbates experimental colitis via inflammasome activation in macrophages: a possible mechanism of chronic enteropathy associated with SLCO2A1 geneRieko Nakata, Yoshinobu Nakamura, Shuhei Hosomi, et al.
Internal Medicine (Tokyo, Japan)|February 23, 2026
An Effective Case of Radiofrequency Ablation with the Combination of Durvalumab and Tremelimumab Treatment for Hepatocellular Carcinoma: A Case ReportKoji Rinka, Kiyohide Kioka, Rika Shioji, et al.
Pageof 8